Innovative Drugs to Restore Neurological Function

  • Home
  • About Us
    • Management
    • Scientific Advisory Board
    • Board of Advisors
  • Disease Focus
    • Technology Focus
      • CCM
      • Spinal Cord Injury
      • Cerebral Vascular Disorder
  • Patients
  • News
  • Contact Us

Patient Resources

General

Information on Clinical Trials can be found at https://clinicaltrials.gov/

Spinal Cord Injury

For patient resources on spinal cord injury, visit: https://www.ninds.nih.gov/Disorders/All-Disorders/Spinal-Cord-Injury-Information-Page

Angioma

For patient resources, please visit the following site: http://www.angioma.org

News

No. 6, 2024: Bioaxone BioSciences is pleased to announce the publication of article “The novel ROCK2 selective inhibitor NRL-1049 preserves the blood-brain barrier after acute injury” The preclinical data shows that NRL-1049 is a promising drug candidate to preserve the blood brain barrier after brain injury. Click here for a link to the publication.
July 5 2024: Dr. Lisa McKerracher has accepted an invitation to serve on the National Lab User Advisory Committee for the International Space Station (ISS). The ISS National Lab has a focus on space-based research to improve life on earth, including the advancement of biological research and neuroscience. The User Advisory committees recommends research priorities and provides assistance for ISS user community issues.
July 5 2024: BioAxone BioSciences Announces Patent Issued for Pharmaceutical Compositions of BA-210 for treatment of spinal cord injury Click here for the full story .

Events

Upcoming scientific conferences on spinal cord injury Click here to access site .
Information on cerebral cavernous malformation Click here to access site .


Address

90 Canal Street
4th Floor
Boston, MA 02114

© 2024 BioAxone Biosciences. All Rights Reserved. Site by SolDesigns.net